Huilai Zhang et al. enrolled 82 patients to systematically investigate the potential associations between HDAC or EZH2 expression and prognosis in PTCL subtypes. This evidence concerns the gene EZH2 and mature T-cell and NK-cell non-Hodgkin lymphoma.